Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Minor site maintenance update: the page now shows Revision: v3.3.2 (replacing v3.3.1) with no changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:31:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.3.1 and removed Revision: v3.2.0, signaling a version update that does not modify the trial details or eligibility.
    Difference
    0.1%
    Check dated 2025-11-24T14:41:51.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page no longer displays a notice about government funding and operating status; the core trial information remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:51:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The new screenshot shows minor UI adjustments and wording edits on the study page, while core content (title, NCT number, eligibility criteria, primary/secondary outcomes) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:14:28.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:00:03.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.1%
    Check dated 2025-09-28T03:11:07.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.